Jenburkt Pharmaceuticals Ltd Business Overview - SOIC x StockScans Report

as of Jul 2026

Jenburkt Pharmaceuticals is a branded formulations house that began in 1985 with three people making medicines on a loan licence, and has since built a portfolio anchored by pain management and vitamin brands that reach over 400,000 pharmacies. The company went public in 1995 and now operates from its own WHO-GMP compliant plant in Sihor, Gujarat, with an in-house R&D centre recognised by the government’s Department of Scientific and Industrial Research. Its recurring approach is to develop first-in-the-world fixed-dose combinations or to be a fast second-mover at a sharply lower price - a pattern visible from its earliest muscle-relaxant launch in 1991 to its COVID-19 antiviral in 2020.

Business segments

Three engines built on the same manufacturing and R&D backbone - a domestic prescription-drug business that carries the house, a small export arm selling the same brands into Africa and Asia, and a young consumer-wellness division that takes the company direct to shoppers for the first time.

1. Domestic branded formulations: the prescription engine that built the house

A field force of medical representatives promotes a stable of doctor-prescribed brands - led by a top-10 vitamin brand and a 30-year-old pain franchise - through a network of super stockists whose inventory the company tracks in real time.

2. International business: the same brands, sold further afield

Exports of branded formulations to distributors in Asia and Africa - a small, legacy business that faces persistent headwinds from currency shortages and regulatory delays in its target markets.

3. Jenburkt Wellness: the over-the-counter bet on direct-to-consumer

A consumer division launched in 2021 that sells natural pain-relief products online and in retail stores - a complete departure from the prescription-only model, built around a single brand, Zixa Strong, that the company is turning into a sports-and-wellness franchise.

Shared manufacturing and R&D backbone

A single plant and a government-recognised R&D centre in Sihor, Gujarat, supply all three engines - the company makes nothing elsewhere and tests everything itself.

Group structure and partners

Jenburkt is a standalone, debt-free company with no subsidiaries and no foreign collaborators - it is promoter-led, listed only on the BSE, and has recently bought adjacent land to expand its sole manufacturing site.